PRECISION PHAGE THERAPY

Vésale Bioscience

New solutions to fight antibiotic resistant infections

Our mission

Vésale Bioscience

Stem from our advanced R&D on bacteriophages, our Mission is to develop robust modern solutions to fight antibiotic-resistant infections.

Antibiotic-resistant infections, also known as antimicrobial resistance (AMR), are a substantial public health issue. From 700 000/y deaths today, the AMR burden is expected to reach ten million/y deaths by 2050, more than cancer.

Our approach is to work on personalized, selective, and specific phage therapies against those multi-resistant bacterial infections.

Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT

Invest to solve the antibiotic resistant crisis

Know more

Vésale Bioscience in the press

They talk about us.

L’Écho

Vésale Bioscience named most innovative start-up in life sciences in Europe at tenth edition of BioFIT

La Libre

Vésale Bioscience enters into an innovative and ambitious collaboration with the Belgian Army

Lpost

Important reinforcement for Vésale Bioscience: the managers of Vésale Bioscience have hired Guillaume de Viron as Chief Financial Officer (CFO) of the research and development (R&D) company